These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 34483032)

  • 1. A prediction model incorporating the BRAF
    Liu S; Liu C; Zhao L; Wang K; Li S; Tian Y; Jiao B; Gui Z; Yu T; Zhang L
    Eur J Surg Oncol; 2021 Nov; 47(11):2774-2780. PubMed ID: 34483032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of prediction models for determining the risk of lateral lymph node metastasis in patients with thyroid papillary carcinoma based on gender stratification.
    Wu WX; Qi GF; Feng JW; Ye J; Hong LZ; Wang F; Liu SY; Jiang Y
    Eur Arch Otorhinolaryngol; 2023 May; 280(5):2511-2523. PubMed ID: 36622416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nomograms for Prediction of High-Volume Lymph Node Metastasis in Papillary Thyroid Carcinoma Patients.
    Feng JW; Ye J; Qi GF; Hong LZ; Hu J; Wang F; Liu SY; Jiang Y
    Otolaryngol Head Neck Surg; 2023 May; 168(5):1054-1066. PubMed ID: 36856043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors and a Prediction Model for Central Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma (cN0).
    Gao X; Luo W; He L; Cheng J; Yang L
    Front Endocrinol (Lausanne); 2021; 12():789310. PubMed ID: 35154002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for central lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study.
    Du J; Yang Q; Sun Y; Shi P; Xu H; Chen X; Dong T; Shi W; Wang Y; Song Z; Shang X; Tian X
    Front Endocrinol (Lausanne); 2023; 14():1288527. PubMed ID: 38047112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction model of cervical lymph node metastasis based on clinicopathological characteristics of papillary thyroid carcinoma: a dual-center retrospective study.
    Liu W; Zhang D; Jiang H; Peng J; Xu F; Shu H; Su Z; Yi T; Lv Y
    Front Endocrinol (Lausanne); 2023; 14():1233929. PubMed ID: 37766691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The synergic effect of BRAF
    Qu HJ; Qu XY; Hu Z; Lin Y; Wang JR; Zheng CF; Tan Z
    Endocr J; 2018 Jan; 65(1):113-120. PubMed ID: 29070763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting factors of central lymph node metastasis and BRAF
    Zhou SL; Guo YP; Zhang L; Deng T; Xu ZG; Ding C; Sun WC; Zhao YW; Kong LF
    World J Surg Oncol; 2021 Jul; 19(1):211. PubMed ID: 34256769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Online Model for Central Lymph Node Metastases in Papillary Thyroid Carcinoma With BRAF V600E Mutation.
    Chen H; Pan WK; Ren SY; Zhou YL
    Am J Clin Oncol; 2024 Aug; 47(8):383-390. PubMed ID: 38664891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nomogram for predicting skip metastasis in cN0 papillary thyroid cancer patients at increased risk of lymph node metastasis.
    Li F; Zhou FJ; Zhu TW; Qiu HL; Zhang XT; Ruan BW; Huang DY
    Adv Clin Exp Med; 2023 Jul; 32(7):753-761. PubMed ID: 36603142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating BRAF
    Zhang Z; Zhang X; Yin Y; Zhao S; Wang K; Shang M; Chen B; Wu X
    BMC Cancer; 2022 Apr; 22(1):461. PubMed ID: 35473554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors associated with preferential lateral lymph node metastasis in papillary thyroid carcinoma.
    Shao L; Wang Z; Dong W; Sun W; Zhang H
    Cancer Med; 2023 Nov; 12(22):20670-20676. PubMed ID: 37905599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomograms based on sonographic and clinicopathological characteristics to predict lateral lymph node metastasis in classic papillary thyroid carcinoma.
    Feng JW; Wu WX; Qi GF; Hong LZ; Hu J; Liu SY; Jiang Y; Ye J
    J Endocrinol Invest; 2022 Nov; 45(11):2043-2057. PubMed ID: 35809195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nomogram for predicting central lymph node metastasis in T1-T2 papillary thyroid cancer with no lateral lymph node metastasis.
    Sun Y; Sun W; Xiang J; Zhang H
    Front Endocrinol (Lausanne); 2023; 14():1112506. PubMed ID: 36817601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nomogram model based on preoperative serum thyroglobulin and clinical characteristics of papillary thyroid carcinoma to predict cervical lymph node metastasis.
    Chang Q; Zhang J; Wang Y; Li H; Du X; Zuo D; Yin D
    Front Endocrinol (Lausanne); 2022; 13():937049. PubMed ID: 35909521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conventional Ultrasound, Immunohistochemical Factors and BRAF
    Chen J; Li XL; Zhao CK; Wang D; Wang Q; Li MX; Wei Q; Ji G; Xu HX
    Ultrasound Med Biol; 2018 Nov; 44(11):2296-2306. PubMed ID: 30100099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating US-guided FNAB, BRAF
    Ma N; Tian HY; Yu ZY; Zhu X; Zhao DW
    Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5565-5574. PubMed ID: 37540271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nomograms for the prediction of lateral lymph node metastasis in papillary thyroid carcinoma: Stratification by size.
    Feng JW; Ye J; Hong LZ; Hu J; Wang F; Liu SY; Jiang Y; Qu Z
    Front Oncol; 2022; 12():944414. PubMed ID: 36248990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
    Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
    Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients.
    Liu C; Xiao C; Chen J; Li X; Feng Z; Gao Q; Liu Z
    BMC Cancer; 2019 Jun; 19(1):622. PubMed ID: 31238891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.